Condition
Acute Lymphobkastic Leukemia clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Acute Lymphobkastic Leukemia clinical trials that are recruiting, at sites in 4 countries (most in Mexico (2), Austria (1), Italy (1)). 1 was first registered in the last 30 days. By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1New in 30 days
- 4Countries
Newest Acute Lymphobkastic Leukemia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Testing immune reconstitution after stem cell transplant in adults with acute lymphoblastic leukemia | — | Vienna and 2 other locations | Recruiting | Oct 28, 2026 |
| Dose-adjusted EPOCH infusions for frail adults with acute lymphoblastic leukemia | — | Mexico City, Mexico City | Recruiting | Dec 2, 2025 |
| Low-dose venetoclax with itraconazole plus TACL chemotherapy for relapsed/refractory Philadelphia‑negative ALL | Phase 2 | Monterrey, Nuevo León | Recruiting | Jun 26, 2025 |
| Evaluating high ammonia levels in patients treated with Erwinia asparaginase | — | Rochester, Minnesota | Recruiting | Sep 19, 2024 |
All recruiting trials (4)
-
Testing immune reconstitution after stem cell transplant in adults with acute lymphoblastic leukemia
This study tests how the immune system recovers after a stem cell transplant in people with ALL to see if certain immune markers, especially T cells, can predict complications.
-
Dose-adjusted EPOCH infusions for frail adults with acute lymphoblastic leukemia
This project will see if a dose-adjusted, infusion-based EPOCH chemotherapy regimen helps frail adults with acute lymphoblastic leukemia tolerate treatment better and live longer.
-
Low-dose venetoclax with itraconazole plus TACL chemotherapy for relapsed/refractory Philadelphia‑negative ALL
This trial tests whether adding low‑dose venetoclax (boosted with itraconazole) to a TACL chemotherapy regimen helps people with relapsed or refractory Philadelphia‑chromosome‑negative acute lymphoblastic leukemia achieve remission and get to stem cell transplant.
-
Evaluating high ammonia levels in patients treated with Erwinia asparaginase
This study is testing how many patients with acute lymphoblastic leukemia treated with Erwinia asparaginase develop high ammonia levels and who might be at risk for this problem.
Related topics
Quick answers
How many Acute Lymphobkastic Leukemia clinical trials are recruiting right now?
4, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Mexico (2 trials), Austria (1 trial), Italy (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.